Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Quantum Biopharma (QNTM) Non-Current Receivables (2022)

Quantum Biopharma's Non-Current Receivables history spans 1 years, with the latest figure at $7.4 million for Q4 2022.

  • On a quarterly basis, Non-Current Receivables changed N/A to $7.4 million in Q4 2022 year-over-year; TTM through Dec 2022 was $7.4 million, a N/A change, with the full-year FY2022 number at $7.4 million, changed N/A from a year prior.
  • Non-Current Receivables hit $7.4 million in Q4 2022 for Quantum Biopharma.
  • Over the last five years, Non-Current Receivables for QNTM hit a ceiling of $7.4 million in Q4 2022 and a floor of $7.4 million in Q4 2022.